We found that untreated early RA and established RA patients have alterations in memory B cell subpopulations, particularly in DN (IgD-CD27-) memory B cells, and treatment with either TNF antagonists or tocilizumab restored the frequency of this B cell subset to normal levels. This evidence concerns the gene CD27 and rheumatoid arthritis.